SCHEMBL4763574

SCHEMBL4763574

CC(C)Cn1c(C=Cc2cnn(-c3ccccc3)c2)c([N+](=O)[O-])c(=O)n(CC(C)C)c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
HSP90AA1 P07900 1/20 0.38
MITF O75030 1/20 0.36
MAPT P10636 4/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
POLB P06746 1/20 0.35
MTOR P42345 2/20 0.35
MAPK1 P28482 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
LMNA P02545 1/20 0.34
ADORA2A P29274 2/20 0.34
ADORA2B P29275 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4763559 1.00 SMN1; SMN2 (0.41) SMN1; SMN2NPC1RAB9AHSP90AA1MITF
SCHEMBL4793245 0.93 NPC1 (0.36) SMN1; SMN2NPC1RAB9AHSP90AA1MITF
SCHEMBL4793254 0.93 NPC1 (0.36) SMN1; SMN2NPC1RAB9AHSP90AA1MITF
SCHEMBL4769599 0.92 NCOA1 (0.39) SMN1; SMN2NPC1RAB9AHSP90AA1MITF
SCHEMBL4769586 0.92 NCOA1 (0.39) SMN1; SMN2NPC1RAB9AHSP90AA1MITF
SCHEMBL4793250 0.91 NPC1 (0.37) SMN1; SMN2NPC1RAB9AHSP90AA1MITF
SCHEMBL4793242 0.90 SMN1; SMN2 (0.37) SMN1; SMN2NPC1RAB9AHSP90AA1MITF
SCHEMBL4792657 0.88 NPC1 (0.44) SMN1; SMN2NPC1RAB9AHSP90AA1MITF
SCHEMBL4792653 0.88 NPC1 (0.44) SMN1; SMN2NPC1RAB9AHSP90AA1MITF
SCHEMBL4767911 0.85 NCOA1 (0.42) SMN1; SMN2NPC1RAB9AHSP90AA1MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed